Purchase Order HHSF223201110491P
- Not listed
- The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
- This is a $23,086.75 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc., doing business as Precision Antibody. Precision Antibody is a for-profit manufacturer of goods that provides custom antibody development services to support biomedical research. This contract is not set aside for small businesses. The award supports research efforts through the...
- This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...
- This $13,670 federal contract was awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc., doing business as Precision Antibody, a for-profit manufacturer of custom antibodies and related products for biomedical research. The contract was issued as a purchase order for the delivery of custom antibodies. Precision Antibody has a strong track record of federal contract awards, primarily from NIH institutes, for providing specialized biological materials and services to...
- This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
- This is a $199,828 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for the development of "TECHNOLOGY GENERATED ANTI-PEPTIDE CAPTURE REAGENTS FOR AFFINITY ENRICHED PROTEOMIC STUDIES." The contract has a performance period ending on July 24, 2014 and was awarded on September 25, 2013. Precision Antibody is a for-profit...
- This is a firm-fixed price Blanket Purchase Agreement (BPA) contract awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for $100 million. The BPA allows various NIH institutes and the Department of Agriculture's Agricultural Research Service to place delivery orders for Precision Antibody's custom biological materials, laboratory and testing services, and animal testing...
- This is a firm-fixed price delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $107,461.88 contract is for the delivery of polyclonal rat antibodies and monoclonal rat antibodies against glycol-chitosan nanoparticles. This award is part of a larger $100 million single-award...
- This federal contract was awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for a COVID-19-related project analyzing a novel truncated form of the ACE2 receptor. The $19,349.65 firm-fixed-price purchase order was awarded on June 18, 2020, with a period of performance through June 19, 2020. The contract was awarded without any set-aside designation, indicating open competition....
This firm-fixed price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $9,750 contract is for the delivery of monoclonal antibodies. Precision Antibody is a for-profit manufacturer of goods that specializes in custom antibody development services to support biomedical research. The company has an extensive history of federal contract awards, primarily from HHS agencies like the National Institutes of Health (NIH), where it has provided a range of antibody products and related services. Most recently, in January 2024, Precision Antibody was awarded a $100 million single-award Blanket Purchase Agreement (BPA) by the NIH Office of Logistics and Acquisition Operations, which allows various NIH institutes and other federal agencies to place firm-fixed price delivery orders for the company's custom antibody development services and related products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 6/1/11 |